1. •Aceleran la velocidad de las reacciones bioquímicas.
•Específicas para un sustrato.
•Reacciones ocurren en ambiente fisiológico (pH, temperatura y presión).
•Proveen para reacciones acopladas
•Algunas funcionan como puntos de regulación en rutas metabólicas.
EnzimasEnzimas
2. Fig. 7-10, p. 162
Activation energy (EA)
without enzyme
Activation energy (EA)
with enzyme
Energy of
reactants
Change
in free
energy
(ΔG)
Freeenergy(G)
Energy of products
Progress of reaction
EnzymesEnzymes
20. The list of enzymes which use zinc as a cofactor are :
1. glutamate dehydrogenase
2. alcohol dehydrogenase
3. lactate dehydrogenase
4. carbonic anhydrase
5. alkaline phosphatase
6. DNA polymerase
7. RNA polymerase
8. delta-ALA dehydratase
9. superoxide dismutase
10. pancreatic carboxypeptidase
21.
22. Cofactor Vitamin
Additional
component
Chemical group(s)
transferred
Distribution
Thiamine pyrophosphate
[24]
Thiamine (B1) None
2-carbon groups, α
cleavage
Bacteria, archaea and
eukaryotes
NAD+
and NADP+ [25] Niacin (B3) ADP Electrons
Bacteria, archaea and
eukaryotes
Pyridoxal phosphate
[26]
Pyridoxine (B6) None
Amino and carboxyl
groups
Bacteria, archaea and
eukaryotes
Lipoamide [3]
Lipoic acid None electrons, acyl groups
Bacteria, archaea and
eukaryotes
Methylcobalamin [27] Vitamin B12 Methyl group acyl groups
Bacteria, archaea and
eukaryotes
Cobalamine [3] Cobalamine (B12) None
hydrogen,
alkyl groups
Bacteria, archaea and
eukaryotes
Biotin [28]
Biotin (H) None CO2
Bacteria, archaea and
eukaryotes
Coenzyme A [29] Pantothenic acid (B5) ADP
Acetyl group and
other acyl groups
Bacteria, archaea and
eukaryotes
Tetrahydrofolic acid
[30]
Folic acid (B9) Glutamate residues
Methyl, formyl,
methylene and
formimino groups
Bacteria, archaea and
eukaryotes
Menaquinone [31]
Vitamin K None
Carbonyl group and
electrons
Bacteria, archaea and
eukaryotes
Ascorbic acid [32]
Vitamin C None Electrons
Bacteria, archaea and
eukaryotes
Flavin
mononucleotide [33]
Riboflavin (B2) None Electrons
Bacteria, archaea and
eukaryotes
Flavin adenine
dinucleotide [33]
Riboflavin (B2) None Electrons
Bacteria, archaea and
eukaryotes
Coenzyme F420 [34] Riboflavin (B2) Amino acids Electrons
Methanogens and
some bacteria
23. Enzymes are used in an increasing number of
application areas including:
a) detergents,
b) food processing,
c) brewing,
d) household products,
e) manufacture of pharmaceuticals molecules,
f) environmental and clinical assay kits, as
labels in immunological ELISA tests and
biosensors.
24. 1,6-Dihydro nicotinamide adenine dinucleotide inhibits both
H-type lactic dehydrogenase and M-type lactic
dehydrogenase which are isoenzymes of lactic
dehydrogenase, but the degree of inhibition thereof against
H-type considerably differs from that against M-type. A ratio
of H-type lactic dehydrogenase to M-type lactic
dehydrogenase in serum can be measured by utilizing the
difference of inhibition degree. Therefore we can diagnose
the organ with trouble.
26. *En solución saturada de sustrato
Vmax = Kcat x [E]total
Kcat = Vmax / [E]total
[E]total= Vmax / Kcat
E + S ES E + P
k1
k-1
k2
Cinética de las Enzimas
K = V/[E]
27. *En solución saturada de
sustrato
Vmax = Kcat x [E]total
Kcat = Vmax / [E]total
[E]total= Vmax / Kcat
28. Kcat = moles de S convertidos a P
por segundo por mol de enzima
(en solución saturada)
En solución saturada de sustrato
Kcat = Vmax / [E]total
29. En solución saturada de sustrato
Vmax = Kcat x [E]total
Kcat = Vmax / [E]total
[E]total= Vmax / Kcat
*En concentración constante de la enzima
y no saturada de sustrato
30. Y= ax
b+x
b = a/2
k2
k-1
k1
E + S ES E + P
Km = k-1/k1 :. Km mayor = menos afinidad Variaciones con las isoenzymas
Michaelis–Menten
equation
37. InhibitionInhibition
• Reversible inhibitionReversible inhibition
•
competitivecompetitive (inhibitor competes with substrate(inhibitor competes with substrate
for active site)for active site)
•
noncompetitivenoncompetitive (inhibitor binds at a different(inhibitor binds at a different
site)site)
• Irreversible inhibitionIrreversible inhibition
•
inhibitor combines with enzyme andinhibitor combines with enzyme and
permanently inactivates itpermanently inactivates it
38.
39.
40.
41.
42.
43.
44.
45.
46.
47. Gas nervioso
inhibidor de aceticolinesterasa
Insecticidas con inhibidor de aceticolinesterasa
Inhibidores de aceticolinesterasa
para el Alzheimer
48. •Regulación de las enzimas en metabolismo
•concentración de la enzimas
•concentración del sustrato
•modulaciones alostéricas
•modificaciones covalentes
•cambios en pH
•temperatura
60. Fig. 7-12b, p. 164
Trypsin
Pepsin
pH
(b) Enzyme activity is very sensitive to pH. Pepsin is a protein-digesting
enzyme in the very acidic stomach juice. Trypsin, secreted by the pancreas
into the slightly basic small intestine, digests polypeptides.
Rateofreaction
61.
62. Fig. 7-12a, p. 164
Most
human
enzymes
Enzymes of
heat-tolerant
bacteria
Rateofreaction
Temperature (°C)
(a) Generalized curves for the effect of temperature on enzyme activity.
80. Fig. 7-17a, p. 167
Substrate
Inhibitor
Enzyme
(a) Competitive inhibition. The inhibitor competes with the normal
substrate for the active site of the enzyme. A competitive inhibitor
occupies the active site only temporarily.
Inhibitor binds to
active site
Substrate
81. Fig. 7-17b, p. 167
Substrates Active site
Inhibitor
(b) Noncompetitive inhibition. The inhibitor binds with the enzyme at a
site other than the active site, altering the shape of the enzyme and
thereby inactivating it.
Active site not suitable
for reception of substratesEnzyme
84. Exergonic ReactionsExergonic Reactions
• have a negativehave a negative ΔΔGG valuevalue
•
free energy decreasesfree energy decreases
• are spontaneousare spontaneous
•
release free energy that can perform workrelease free energy that can perform work
85. Endergonic ReactionsEndergonic Reactions
• have a positivehave a positive ΔΔGG valuevalue
•
free energy increasesfree energy increases
• areare notnot spontaneousspontaneous
87. Fig. 7-3a, p. 156
Reactants
Free energy
decreases
Freeenergy(G)
Products
Course of reaction
(a) In an exergonic reaction, there is a net loss
of free energy. The products have less free
energy than was present in the reactants, and
the reaction proceeds spontaneously.
88. Fig. 7-3b, p. 156
Reactants
Free energy
increases
Freeenergy(G)
Products
Course of reaction
(b) In an endergonic reaction, there is a net gain
of free energy. The products have more free
energy than was present in the reactants.
89. Coupled ReactionCoupled Reaction
• Input of free energy required to drive anInput of free energy required to drive an
endergonic reactionendergonic reaction is supplied by anis supplied by an
exergonic reactionexergonic reaction
A→A→BB ΔΔG = +20.9 kJ/molG = +20.9 kJ/mol
C→C→DD ΔΔG = -33.5 kJ/molG = -33.5 kJ/mol
OverallOverall ΔΔG = -12.6 kJ/molG = -12.6 kJ/mol
90. Learning Objective 9Learning Objective 9
• How can anHow can an enzymeenzyme lower the requiredlower the required
energy of activationenergy of activation for a reaction?for a reaction?
92. Catabolism and AnabolismCatabolism and Anabolism
• CatabolismCatabolism
•
degradation of large complex molecules intodegradation of large complex molecules into
smaller, simpler moleculessmaller, simpler molecules
•
exergonicexergonic
• AnabolismAnabolism
•
synthesis of complex molecules from simplersynthesis of complex molecules from simpler
moleculesmolecules
•
endergonicendergonic
93. ATP Links Exergonic andATP Links Exergonic and
Endergonic ReactionsEndergonic Reactions
Figure 7.10: Activation energy and enzymes.
An enzyme speeds up a reaction by lowering its activation energy (EA). In the presence of an enzyme, reacting molecules require less kinetic energy to complete a reaction.
Figure 5.4
Plots of initial velocity 0 versus substrate concentration ([S]) for an enzyme-catalyzed reaction. (a) Each experimental point is obtained from a separate progress curve using the same concentration of enzyme. The shape of the curve is hyperbolic. At low substrate concentrations, the curve approximates a straight line that rises steeply. In this region of the curve, the reaction is highly dependent on the concentration of substrate. At high concentrations of substrate, the enzyme is almost saturated, and the initial rate of the reaction does not change much when substrate concentration is further increased. (b) The concentration of substrate that corresponds to half-maximum velocity is called the Michaelis constant (Km). The enzyme is half-saturated when S = Km.
Figure 6.15
Inhibition of adenosine deaminase by a transition-state analog. (a) In the deamination of adenosine, a proton is added to N-1 and a hydroxide ion is added to C-6 to form an unstable covalent hydrate, which decomposes to produce inosine and ammonia. (b) The inhibitor purine ribonucleoside also rapidly forms a covalent hydrate, 6-hydroxy-1,6-dihydropurine ribonucleoside. This covalent hydrate is a transition-state analog that binds more than a million times more avidly than another competitive inhibitor, 1,6-dihydropurine ribonucleoside (c), which differs from the transition-state analog only by the absence of the 6-hydroxyl group.
Figure 5.8
Diagrams of reversible enzyme inhibition. In this scheme, catalytically competent enzymes are green and inactive enzymes are red. (a) Classical competitive inhibition. S and I bind to the active site in a mutually exclusive manner. (b) Nonclassical competitive inhibition. The binding of S at the active site prevents the binding of I at a separate site, and vice versa. (c) Uncompetitive inhibition. I binds only to the ES complex. The enzyme becomes inactive when I binds. (d) Noncompetitive inhibition. I can bind to either E or ES. The enzyme becomes inactive when I binds. Although the EI complex can still bind S, no product is formed.
Figure 5.9
Competitive inhibition. (a) Kinetic scheme illustrating the binding of I to E. Note that this is an expansion of Equation 5.11 that includes formation of the EI complex. (b) Double-reciprocal plot. In competitive inhibition, Vmax remains unchanged and Km increases. The black line labeled “Control” is the result in the absence of inhibitor. The red lines are the results in the presence of inhibitor, with the arrow showing the direction of increasing [I].
Figure 5.8
Diagrams of reversible enzyme inhibition. In this scheme, catalytically competent enzymes are green and inactive enzymes are red. (a) Classical competitive inhibition. S and I bind to the active site in a mutually exclusive manner. (b) Nonclassical competitive inhibition. The binding of S at the active site prevents the binding of I at a separate site, and vice versa. (c) Uncompetitive inhibition. I binds only to the ES complex. The enzyme becomes inactive when I binds. (d) Noncompetitive inhibition. I can bind to either E or ES. The enzyme becomes inactive when I binds. Although the EI complex can still bind S, no product is formed.
Figure 5.11
Uncompetitive inhibition. (a) Kinetic scheme illustrating the binding of I to ES. (b) Double-reciprocal plot. In uncompetitive inhibition, both Vmax and Km decrease (i.e., the absolute values of both 1/Vmax and 1/Km obtained from the y and x intercepts, respectively, increase). The ratio Km/ Vmax, the slope of the lines, remains unchanged.
Figure 5.8
Diagrams of reversible enzyme inhibition. In this scheme, catalytically competent enzymes are green and inactive enzymes are red. (a) Classical competitive inhibition. S and I bind to the active site in a mutually exclusive manner. (b) Nonclassical competitive inhibition. The binding of S at the active site prevents the binding of I at a separate site, and vice versa. (c) Uncompetitive inhibition. I binds only to the ES complex. The enzyme becomes inactive when I binds. (d) Noncompetitive inhibition. I can bind to either E or ES. The enzyme becomes inactive when I binds. Although the EI complex can still bind S, no product is formed.
Figure 5.12
Classic noncompetitive inhibition. (a) Kinetic scheme illustrating the binding of I to E or ES. (b) Double-reciprocal plot. Vmax decreases, but Km remains the same.
Figure 5.20
The R conformation of phosphofructokinase-1 from E. coli. The enzyme is a tetramer of identical chains. (a) Single subunit, shown as a ribbon. The products, fructose 1,6-bisphosphate (yellow) and ADP (green), are bound in the active site. The allosteric activator ADP (red) is bound in the regulatory site. (b) Tetramer. Two are blue, and two are purple. The products, fructose 1,6-bisphosphate (yellow) and ADP (green), are bound in the four active sites. The allosteric activator ADP (red) is bound in the four regulatory sites, at the interface of the subunits. [PDB 1PFK].
Figure 5.23
Conformational changes during oxygen binding to hemoglobin. The tertiary structure of a single chain changes as oxygen is bound. The quaternary structure of hemoglobin changes from the T state to the R state only when at least one subunit on each dimer is oxygenated. Only four of the eight possible partially oxygenated species are shown (e.g., oxygen could bind initially to either an or a chain, and so on). [Adapted from Ackers, G. K., Doyle, M. L., Myers, D., and Daugherty, M. A. (1992). Molecular code for cooperativity in hemoglobin. Science 255:54–63.]
Figure 5.22
Two models for cooperativity of binding of substrate (S) to a tetrameric protein. (a) In the simplified concerted model, all subunits are either in the R state or the T state, and S binds only to the R state. (b) In the sequential model, binding of S to a subunit converts only that subunit to the R conformation. Neighboring subunits might remain in the T state or might assume conformations between T and R.
Figure 5.17
Plot of initial velocity as a function of substrate concentration for an allosteric enzyme exhibiting cooperative binding of substrate.
Figure 5.24
Regulation of mammalian pyruvate dehydrogenase. Pyruvate dehydrogenase, an interconvertible enzyme, is inactivated by phosphorylation catalyzed by pyruvate dehydrogenase kinase. It is reactivated by hydrolysis of its phosphoserine residue, catalyzed by an allosteric hydrolase called pyruvate dehydrogenase phosphatase.
Figure 7.12: The effects of temperature and pH on enzyme activity.
Substrate and enzyme concentrations are held constant in the reactions illustrated.
Figure 7.12: The effects of temperature and pH on enzyme activity.
Substrate and enzyme concentrations are held constant in the reactions illustrated.
Figure 6.7
General acid–base catalysis mechanism proposed for the reaction catalyzed by triose phosphate isomerase.
Figure 6.27
Mechanism of chymotrypsin-catalyzed cleavage of a peptide bond.
Figure 6.27
Mechanism of chymotrypsin-catalyzed cleavage of a peptide bond.
Figure 6.27
Mechanism of chymotrypsin-catalyzed cleavage of a peptide bond.
Figure 6.27
Mechanism of chymotrypsin-catalyzed cleavage of a peptide bond.
a) Chymotrypsin b) trypsin c) elastase
Figure 6.17
Structure of a four-residue portion of a bacterial cell-wall polysaccharide. Lysozyme catalyzes hydrolytic cleavage of the glycosidic bond between C-1 of MurNAc and the oxygen atom involved in the glycosidic bond.
Figure 6.18
Lysozyme from chicken with a trisaccharide molecule (pink). The ligand is bound in sites A, B, and C. Three more monosaccharide residues can fit into a model of this active site, but the sugar residue in site D must be distorted. [PDB 1HEW].
Figure 6.20
Mechanism of lysozyme. R1 represents the lactyl group, and R2 represents the N-acetyl group of MurNAc.
Figure 6.20
Mechanism of lysozyme. R1 represents the lactyl group, and R2 represents the N-acetyl group of MurNAc.
Figure 6.20
Mechanism of lysozyme. R1 represents the lactyl group, and R2 represents the N-acetyl group of MurNAc.
Figure 7.17: Competitive and noncompetitive inhibition.
Figure 7.17: Competitive and noncompetitive inhibition.
Figure 7.3: Exergonic and endergonic reactions.
Figure 7.3: Exergonic and endergonic reactions.
Figure 7.3: Exergonic and endergonic reactions.
Figure 7.7: NAD+ and NADH.
NAD+ consists of two nucleotides, one with adenine and one with nicotinamide, that are joined at their phosphate groups. The oxidized form of the nicotinamide ring in NAD+ (left) becomes the reduced form in NADH (right) by the transfer of 2 electrons and 1 proton from another organic compound (XH2), which becomes oxidized (to X) in the process.